Related Experiment Video
Updated: Apr 23, 2026
Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Sodium and copeptin levels in children with community acquired pneumonia
August Wrotek1, Teresa Jackowska, Katarzyna Pawlik
1Department of Pediatrics, Medical Center of Postgraduate Education, 99/103 Marymoncka St., Warsaw, 01-813, Poland.
Insights
Copeptin levels are higher in children with pneumonia, indicating it may be a useful diagnostic marker. However, it does not accurately reflect disease severity or sodium balance.
Area of Science:
- Pediatrics
- Infectious Diseases
- Biomarkers
Background:
- Copeptin, a marker of arginine vasopressin, is linked to pneumonia severity and complications.
- Assessing copeptin's utility in pediatric community-acquired pneumonia (CAP) is crucial for understanding its diagnostic and prognostic value.
Purpose of the Study:
- To evaluate the usefulness of copeptin measurement in children diagnosed with CAP.
- To investigate the relationship between copeptin levels, disease severity, and sodium equilibrium in pediatric CAP patients.
Main Methods:
- A study involving 311 participants (227 with CAP, 84 healthy controls) aged 8 days to 18 years.
- Clinical findings and inflammatory markers were utilized to assess disease severity.
- Receiver Operating Characteristic (ROC) analysis was performed to determine diagnostic accuracy.
Main Results:
- Copeptin levels were significantly elevated in CAP patients compared to healthy controls (0.88 vs. 0.33 ng/mL).
- A copeptin cut-off of 0.44 ng/mL demonstrated high sensitivity (89%) and specificity (73%) for pneumonia detection.
- Higher copeptin concentrations correlated with an increased risk of hyponatremia, though the correlation with sodium levels was weak.
Conclusions:
- Copeptin elevation is a promising indicator for identifying pneumonia in children.
- Copeptin levels do not reliably reflect the severity of community-acquired pneumonia or correlate strongly with sodium concentration.
Abstract:
Copeptin has been associated with the severity of pneumonia and its complications. This study was designed to assess the usefulness of copeptin measurement in children with community-acquired pneumonia (CAP) and copeptin's relation with disease severity and sodium equilibrium. The study encompassed 311 patients (227 with pneumonia and 84 healthy controls) aged 8 days-18 years. Clinical findings and inflammatory markers were used to predict the disease severity. We found that the level of copeptin was significantly higher in patients with CAP (median 0.88 ng/mL) vs. healthy children (0.33 ng/mL; p < 0.01). ROC analysis showed a high AUC value (0.87) and the cut-off point for plasma copeptin level was 0.44 ng/mL, with a high sensitivity (89 %) and specificity (73 %) in recognizing pneumonia. Patients with higher copeptin concentrations were at higher risk of hyponatremia (OR 2.43). Yet there was only a weak reverse correlation between the sodium and the copeptin concentrations (Spearmann's rank coefficient = -0.19). The levels of copeptin were higher in hyponatremic patients (0.83 ng/mL) vs. normonatremic patients (0.69 ng/mL; p = 0.02). Copeptin elevation did not reflect the CAP severity measured with traditionally used methods. In conclusion, copeptin elevation is a promising marker of pneumonia, but it reflects neither the disease severity nor sodium concentration.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
01:29Drug Dosing: Infants and Children